The company remains pre-revenue. Operations at the Aurora facility are scheduled to begin in 2028, while the Meta arrangement won’t achieve maximum output until 2034.
UBS adjusted its valuation framework, reducing its 2034 EV/EBITDA multiple from 20x to 15x, discounted over seven years using Oklo’s equity cost. Analysts explained the compressed multiple better captures the inherent risks associated with early-stage nuclear technology ventures and now corresponds with industry peer averages.
This adjustment represents approximately a five-point contraction from UBS’s previous modeling approach when benchmarked against comparable nuclear sector companies.
Oklo maintains a stronger cash position than outstanding liabilities, boasting a current ratio of 49.08 — providing crucial financial cushion for a pre-revenue enterprise. Market analysts anticipate the company will remain unprofitable throughout this year.
Craig-Hallum similarly reduced its outlook to $71 from $87, emphasizing capital requirements. Needham trimmed its forecast to $73 from $135 based on revised deployment timelines while preserving its Buy recommendation. William Blair maintained its Outperform rating, highlighting the Aurora reactor’s initial design clearance from the Department of Energy.
Oklo’s Chief Executive Jacob DeWitte recently received appointment to the President’s Council of Advisors on Science and Technology. The Aurora facility secured initial design authorization from the Department of Energy through the Reactor Pilot Program.
The Meta partnership encompasses constructing power generation facilities in Ohio capable of supplying 1.2 gigawatts of electricity. Meta is providing advance payments for power delivery, supplying Oklo with crucial upfront funding before establishing meaningful revenue generation.
Revenue projections show $0.1M for 2026, escalating to $3.3M in 2027, then jumping to $228M by 2030 and $1.1B in 2031. Even assuming these targets materialize, the current $55 stock price implies approximately 8.5x 2031 revenue multiples.
Shares have declined roughly 50% during the previous six-month period, although they remain elevated by approximately 109% year-over-year. The stock currently trades about 68% beneath its late 2025 peak of $193.84.
At present trading levels, Oklo commands a market capitalization near $9.4 billion — representing substantial expectations for an enterprise lacking revenue and facing multi-year timelines before operational facilities.
InvestingPro’s Fair Value assessment indicates potential overvaluation at existing price points.
The 52-week floor registers at $17.42. Daily trading volume averages roughly 10 million shares. Recent Wall Street price objectives span from $60 (UBS, Neutral) to $73 (Needham, Buy), with Craig-Hallum positioned at $71 (Hold) and William Blair sustaining an Outperform designation.
The post Oklo (OKLO) Stock Plunges 50% in Half a Year — Should Investors Buy the Dip? appeared first on Blockonomi.
